Blood Coagulation Disorder
27
4
4
15
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.7%
1 terminated out of 27 trials
93.8%
+7.2% vs benchmark
7%
2 trials in Phase 3/4
7%
1 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (27)
Investigation of the Genetics of Hematologic Diseases
The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)
Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery
Transfusion Surveillance in Anaesthesia
Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD)
The Fear F8ctor Study - Does Fear Induce a Blood Curdling State?
Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on Anticoagulants
The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin
Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors
Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants
Biomarkers and Prediction of Tigecycline Induced Coagulation Dysfunction
Ondansetron and Blood Coagulation
Palonosetron and Blood Coagulation
AAV Gene Therapy Screening/Observational Protocol (ECLIPSE)
Hypercoagulability Study Using Haemostatic Techniques in Patients With Inflammatory Bowel Disease
Dexmedetomidine and Blood Coagulation
Comparison of Two D-Dimers Dosing Techniques
Plasmalyte-148 Solution and Blood Coagulation
Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation
NOAC Plasma Concentration and Blood Coagulation in Healthy Volunteers